🔎 Trials Near Me

Akèy › Kansè orofaringe › Nebraska › Omaha

Etid klinik pou Kansè orofaringe nan Omaha, NE

5 etid pou Kansè orofaringe ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Ap rekriteFaz 2
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07195734

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06305676

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

Integrated Cancer Repository for Cancer Research

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Methodist Estabrook Cancer Center, Omaha
  • Nebraska Methodist Health System, Omaha
  • University of Nebraska Medical Center, Omaha
  • ak 1 plis
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Etid Kansè orofaringe nan lòt vil

Lòt etid nan Omaha

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.